Inventor
MOGENSEN JOHN PATRICK
DK25 patents
⚠️ This page may combine multiple inventors who share the name “MOGENSEN JOHN PATRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
16 patentsUS6225310B1May 1, 2001
Fused 1,2,4-thiadiazine derivatives, their preparation and use
NOVO NORDISK AS75 citations95
US7202213B2Apr 10, 2007
Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders
NOVO NORDISK AS21 citations92
US7091245B2Aug 15, 2006
Compounds, their preparation and use
NOVO NORDISK AS22 citations92
US7067530B2Jun 27, 2006
Compounds, their preparation and use
NOVO NORDISK AS22 citations92
US6869967B2Mar 22, 2005
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
NOVO NORDISK AS26 citations92
US6569901B2May 27, 2003
Alkynyl-substituted propionic acid derivatives, their preparation and use
NOVO NORDISK AS33 citations92
US6555577B1Apr 29, 2003
Compounds, their preparation and use
NOVO NORDISK AS28 citations92
US7358238B2Apr 15, 2008
Pharmaceutical use of fused 1,2,4-triazoles
NOVO NORDISK AS36 citations90
US7220877B2May 22, 2007
Compounds, their preparation and use
NOVO NORDISK AS12 citations84
US7129268B2Oct 31, 2006
Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
NOVO NORDISK AS20 citations84
US6867218B2Mar 15, 2005
Compounds, their preparation and use
NOVO NORDISK AS17 citations84
US6147098ANov 14, 2000
Substituted guanidines and diaminonitroethenes, their preparation and use
NOVO NORDISK AS19 citations82
US6242443B1Jun 5, 2001
1,2,4-benzothiadiazine derivatives, their preparation and use
NOVO NORDISK AS12 citations71
US6509374B2Jan 21, 2003
Compounds, their preparation and use
NOVO NORDISK AS1 citations52
US6365609B1Apr 2, 2002
Substituted 3,3-diamino-2-propenenitriles, their preparation and use
NOVO NORDISK AS0 citations39
US6362205B2Mar 26, 2002
Substituted 3,3-diamino-2-propenenitriles, their preparation and use
NOVO NORDISK AS0 citations39
VTV THERAPEUTICS LLC
5 patentsUS10471066B2Nov 12, 2019
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
VTV THERAPEUTICS LLC6 citations84
US9855274B2Jan 2, 2018
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
VTV THERAPEUTICS LLC7 citations84
US9663481B2May 30, 2017
Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists
VTV THERAPEUTICS LLC7 citations84
US10947180B2Mar 16, 2021
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
VTV THERAPEUTICS LLC4 citations81
US11420929B2Aug 23, 2022
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
VTV THERAPEUTICS LLC0 citations62
HIGH POINT PHARMACEUTICALS LLC
4 patentsUS8551993B2Oct 8, 2013
Phenoxy acetic acids as PPAR delta activators
HIGH POINT PHARMACEUTICALS LLC13 citations92
US8362016B2Jan 29, 2013
Phenyl propionic acids as PPAR delta activators
HIGH POINT PHARMACEUTICALS LLC15 citations92
US7943613B2May 17, 2011
Compounds, their preparation and use
HIGH POINT PHARMACEUTICALS LLC22 citations92
US7723323B2May 25, 2010
Pharmaceutical use of fused 1,2,4-triazoles
HIGH POINT PHARMACEUTICALS LLC32 citations90